Activation of the hypothalamic serotoninergic system by central interleukin-1.
Gemma
C
C
Istituto di Richerche Farmacologiche Mario Negri, Milan, Italy.
Ghezzi
P
P
De Simoni
M G
MG
D000818:Animals; D002244:Carbon; D004566:Electrodes; D005110:Extracellular Space / Q000378:metabolism; D006897:Hydroxyindoleacetic Acid / Q000378:metabolism; D007030:Hypothalamo-Hypophyseal System / Q000187:drug effects; D007032:Hypothalamus, Anterior / Q000187:drug effects* / Q000502:physiology; D007375:Interleukin-1 / Q000494:pharmacology*; D008297:Male; D010913:Pituitary-Adrenal System / Q000187:drug effects; D011903:Raphe Nuclei / Q000502:physiology; D051381:Rats; D011971:Receptors, Immunologic / Q000037:antagonists & inhibitors; D017472:Receptors, Interleukin-1; D011994:Recombinant Proteins / Q000494:pharmacology; D012701:Serotonin / Q000378:metabolism / Q000502:physiology*
D007375:Interleukin-1; D011971:Receptors, Immunologic; D017472:Receptors, Interleukin-1; D011994:Recombinant Proteins; D012701:Serotonin; D006897:Hydroxyindoleacetic Acid; D002244:Carbon